Guide to BioTerminology 2nd edition - - BioPharm International


Guide to BioTerminology 2nd edition

BioPharm International

process development The step in the life cycle of a product that starts with information from research, and delivers a scalable process to manufacturing plants that can be validated, operated under cGMP controls, and be commercially viable. During process development, pre-clinical and clinical trials supplies of the product are manufactured.

process knowledge A compilation of all facts about a manufacturing process from development through full-scale manufacture.

process robustness Ability of a process to tolerate variability of materials and changes of the process and equipment without negative impact on quality. [ICH Q8]

process understanding Comprehension of process knowledge such that all critical sources of variability are identified and explained; variability is managed by the process; and product quality attributes can be accurately and reliably predicted over the design space established for the materials and process. Through process understanding, process performance and product attributes can be explained logically and scientifically as a function of process parameters, inputs, and input material attributes.

product lifecycle All phases in the life of the product from the initial development through marketing until the product's discontinuation [from ICH Q9].

prodrug A modified version or precursor of a parent compound designed to enhance delivery properties and be converted to the parent compound in the body.

product specification A list of tests and acceptance criteria (limits) that are used to define the quality of a drug substance or drug product. The specification is often listed on the Certificate of Analysis along with results for a specific batch or lot.

product variant A molecule that is related to the product but differs from it chemically, such as a degradation product, intermediate, or different configuration of the protein of interest due to deamidation or other chemical reactions.

prokaryotes Simple organisms, such as bacteria, with no cell nuclei and only a few cell organelles.

In addition to chromatography, recovery and purification efforts most often include one or more filtration steps using filters like these.
protease An enzyme that cleaves the peptide bonds linking amino acids in protein molecules, classified according to the most prominent functional molecular group (such as serine or cysteine) at the active site; also called proteinase.

proteinase K A serine protease (used in molecular cloning and DNA sequencing, nucleic acid research, and protein and peptide structural analysis) with broad specificity toward aliphatic, aromatic, and other hydrophobic amino acids, cleaving their peptide bonds.

protein truncation Shortening a polymeric chain of amino acids; the protein truncation test developed by Dutch researchers screens proteins to identify abnormally short molecules that suggest the location of genetic mutations

protein variants Proteins with the same amino acid sequences but different folds or different carbohydrate residues. They must be separated from the therapeutic proteins.

proteins Complex organic macromolecules whose structures are coded in an organism's DNA. Each is a chain of more than 40 amino acids in peptide linkages that folds back upon itself in a particular way. Proteins are the principal constituent of all cell protoplasms (the entire contents of a live cell). Each protein has a unique, genetically defined amino acid sequence that determines its specific shape and function (as enzymes, structural elements, hormones, and immunoglobulins, involved in oxygen transport, muscle contraction, or electron transport, for instance).

proteolysis Separation (cleavage) of peptide bonds in proteins by proteases (enzymes that recognize and cut specific peptide bonds) or other means.

proteolytic Capable of lysing (denaturing, or breaking down) proteins.

proteomics Study of protein function and structure.

protocols Documentation (submitted to FDA or other agency in support of regulatory filings) that directs the work performed in an FDA-regulated company. Protocols tell who directs which activities, who approves what, and who is allowed to sign off on materials and products, even where to find specific files and documents — all tying together numerous SOPs.

blog comments powered by Disqus



Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here